Indianapolis, United States
Elanco, a renowned name in the Biotechnology, Health Care, and Pharmaceutical industries, operates under the compelling slogan, "Making life better for animals, makes life better." Founded in 1954, this American company has been dedicated to enhancing animal health globally through innovative products and services for both pets and farm animals.
Elanco is built on the principle that "Healthier animals are the key to making our lives better," and seeks to be a unique force for good within society. Its Elanco Healthy Purpose™ framework emphasizes sustainable solutions that benefit animals, people, and the planet, also allowing employees paid time off to volunteer and give back.
Recently, Elanco received a significant $250.00M post-IPO equity investment on 30 December 2023 from Ancora. This investment underlines Elanco's strong market presence and commitment to advancing its mission, presenting a strategic investment opportunity in a company renowned for its societal and environmental impacts.
